“Ultimately, the success of next-generation delivery technologies will depend on how well we align performance with real-world deployability.”
Abi Pinchbeck (Editor, Cell & Gene Therapy Insights) speaks with Brenna Kelley-Clarke (Independent Consultant) about emerging paradigms in gene delivery, the evolving relationship between viral and non-viral systems, and the analytical and regulatory frameworks shaping the field’s future.
